ANI Pharmaceuticals Inc (ANIP) – Company Profile and SWOT Analysis

ANI Pharmaceuticals Inc (ANIP) – Company Profile & SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

ANI Pharmaceuticals Inc (ANI) is a biopharmaceutical company. It focuses on developing, manufacturing, and marketing generic and branded prescription pharmaceuticals. The company also offers over-the-counter (OTC) medicines and pharmaceuticals for rare diseases. ANI also conducts business as a contract development and manufacturing organization (CDMO) that assists in late-stage development to commercial manufacturing of pharmaceutical products, which include tablets and capsules, ointments, creams, liquids, oral suspensions, gels, injections, topical, powder and enema products. The company distributes its products through wholesalers, retail market chains, distributors and mail-order pharmacies, group purchasing organizations, specialty pharmacies and hospitals. ANI is headquartered in Baudette, Minnesota, the US.

Scope

• Detailed information on ANI Pharmaceuticals Inc required for business and competitor intelligence needs

• A study of the major internal and external factors affecting ANI Pharmaceuticals Inc in the form of a SWOT analysis

• An in-depth view of the business model of ANI Pharmaceuticals Inc including a breakdown and examination of key business segments

• News about ANI Pharmaceuticals Inc, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of ANI Pharmaceuticals Inc and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess ANI Pharmaceuticals Inc as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on ANI Pharmaceuticals Incs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Teva Pharmaceutical Industries Ltd

Keenova Therapeutics plc

Glenmark Pharmaceuticals Ltd

Strides Pharma Inc

Hikma Pharmaceuticals Plc

Zydus Pharmaceuticals USA Inc

Rising Pharma Holdings Inc

Par Pharmaceutical Inc

Alvogen Inc

Viatris Inc

Sun Pharmaceutical Industries Ltd

Aurobindo Pharma Ltd

Camber Pharmaceuticals Inc

Lupin Pharmaceuticals Inc

Apotex Inc

Amneal Pharmaceuticals Inc

Amgen Inc

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

ANI Pharmaceuticals Inc - Key Facts

ANI Pharmaceuticals Inc - Key Employees

ANI Pharmaceuticals Inc - Key Employee Biographies

ANI Pharmaceuticals Inc - Major Products and Services

ANI Pharmaceuticals Inc - History

ANI Pharmaceuticals Inc - Company Statement

ANI Pharmaceuticals Inc - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

ANI Pharmaceuticals Inc - Business Description

Business Segment: Generics and Other

Overview

Performance

Business Segment: Rare Disease and Brands

Overview

Performance

Geographical Segment: International

Performance

Geographical Segment: United States

Performance

R&D Overview

ANI Pharmaceuticals Inc - Corporate Strategy

ANI Pharmaceuticals Inc - SWOT Analysis

SWOT Analysis - Overview

ANI Pharmaceuticals Inc - Strengths

ANI Pharmaceuticals Inc - Weaknesses

ANI Pharmaceuticals Inc - Opportunities

ANI Pharmaceuticals Inc - Threats

ANI Pharmaceuticals Inc - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

ANI Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026

ANI Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026

ANI Pharmaceuticals Inc, Recent Deals Summary

Section 5 – Company’s Recent Developments

Feb 24, 2026: ANI Pharmaceuticals to Present at Upcoming Investor Conferences

Jan 12, 2026: Ani Pharmaceuticals Highlights Significant Growth in 2025, Provides 2026 Financial Guidance, and Outlines Strategic Priorities

Dec 02, 2025: Ani Pharmaceuticals Announces Formation of “Futurevision Advisory Council” To Help Strategically Guide Ophthalmology and Retina Franchise

Dec 01, 2025: ANI Pharmaceuticals Announces Board Chair Transition

Aug 25, 2025: ANI Pharmaceuticals to Present at Upcoming Investor Conferences

Aug 08, 2025: Ani Pharmaceuticals Reports Record Second Quarter 2025 Financial Results and Raises 2025 Guidance

Aug 01, 2025: ANI Pharmaceuticals to Discuss Second Quarter 2025 Financial Results on August 8, 2025, at 8:30 a.m. ET

Jul 29, 2025: Delaware Superior Court Jury Issues Unanimous Verdict that CG Oncology Owes No Future Royalties or Other Payments to ANI Pharmaceuticals

Apr 09, 2025: ANI Pharmaceuticals to Discuss First Quarter 2025 Financial Results on May 9, 2025, at 8:00 a.m. ET

Mar 31, 2025: ANI Pharmaceuticals to Present at 2025 RBC Capital Markets Ophthalmology Virtual Conference

Section 6 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

ANI Pharmaceuticals Inc, Key Facts

ANI Pharmaceuticals Inc, Key Employees

ANI Pharmaceuticals Inc, Key Employee Biographies

ANI Pharmaceuticals Inc, Major Products and Services

ANI Pharmaceuticals Inc, History

ANI Pharmaceuticals Inc, Other Locations

ANI Pharmaceuticals Inc, Subsidiaries

ANI Pharmaceuticals Inc, Key Competitors

ANI Pharmaceuticals Inc, Ratios based on current share price

ANI Pharmaceuticals Inc, Annual Ratios

ANI Pharmaceuticals Inc, Annual Ratios (Cont…1)

ANI Pharmaceuticals Inc, Annual Ratios (Cont…2)

ANI Pharmaceuticals Inc, Interim Ratios

ANI Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026

ANI Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026

ANI Pharmaceuticals Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

ANI Pharmaceuticals Inc, Performance Chart (2021 – 2025)

ANI Pharmaceuticals Inc, Ratio Charts

ANI Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026

ANI Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2020 to YTD 2026

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports